WO/2016/077858 BIOMARKERS OF DISEASE AND THEIR USE IN DISEASE DETECTION AND MANAGEMENT||WO||26.05.2016|
||PCT/AU2014/050359||THE UNIVERSITY OF QUEENSLAND ||PUNYADEERA, Chamindie |
The present invention discloses methods and reagents for determining the likelihood of the presence or absence of head and neck cancer or susceptibility to head and neck cancer, including virus infection positive and virus infection negative head and neck cancer, and for monitoring, treatment, response to therapy and management of these conditions. The invention has practical use in early diagnosis of head and neck cancer and in enabling better treatment and management decisions to be made in clinically and sub-clinically affected subjects. The determination or diagnosis is made by the analysis of salivary miRNA obtained from the subject.
WO/2016/077859 METHODS AND PRODUCTS FOR LABELLING LIPIDS||WO||26.05.2016|
||PCT/AU2015/000159||UNIVERSITY OF SOUTH AUSTRALIA ||BROOKS, Doug |
The present disclosure relates to methods and products for labelling, binding and/or detection of lipids. Certain embodiments provide a method of labelling a lipid. The method comprises exposing the lipid to a complex comprising a transition metal carbonyl compound, a conjugated bidentate ligand and a tetrazolato compound, and thereby labelling the lipid by binding the complex to the lipid.
WO/2016/077860 A SEAT CUSHION||WO||26.05.2016|
||PCT/AU2015/000455||GREGORY COMMERCIAL FURNITURE PTY LIMITED ||DOWNES, Scott |
There is disclosed a seat cushion (10), including a forward portion (22) for supporting the upper thighs of a sitter. The forward portion (22) is formed from at least a first resilient material. The seat cushion (10) further includes a rearward portion (24) for supporting the buttocks of the sitter. The rearward portion (24) is formed from a second resilient material, which is relatively softer than the first resilient material. The seat cushion (10) further includes an upwardly open transverse crevice (30) defined between the forward portion (22) and the rearward portion (24). The seat cushion (10) further includes a pair of intermediate portions (38, 40) for supporting the ischial tuberosities of the sitter. The intermediate portions (38, 40) are formed from a third resilient material, which is relatively firmer than the second resilient material. Each intermediate portion (38, 40) is embedded within the forward and rearward portions (22, 24) and extending across the transverse crevice (30). The intermediate portions (38, 40) are laterally spaced apart such that, in use, each intermediate portion (38, 40) is locatable below a respective ischial tuberosity of the sitter.
WO/2016/077882 METHOD AND DEVICE FOR DETECTING A NEURAL RESPONSE IN NEURAL MEASUREMENTS||WO||26.05.2016|
||PCT/AU2015/050724||SALUDA MEDICAL PTY LTD ||PARKER, John Louis |
A method is provided for processing a neural measurement obtained in the presence of noise, in order to detect whether a locally evoked neural response is present in the neural measurement. A first neural measurement is obtained from a first sense electrode. A second neural measurement is contemporaneously obtained from a second sense electrode spaced apart from the first electrode along a neural pathway of the neural response. A neural response decay is determined, being a measure of the decay in the neural response from the first sense electrode to the second sense electrode. A ratio of the neural response decay to an amplitude normalising term is calculated. From the ratio it is determined whether a locally evoked neural response is present in the neural measurement.
WO/2016/077881 GLYCOPROTEIN BIOMARKERS FOR ESOPHAGEAL ADENOCARCINOMA AND BARRETT'S ESOPHAGUS AND USES THEREOF||WO||26.05.2016|
||PCT/AU2015/050723||THE UNIVERSITY OF QUEENSLAND ||HILL, Michelle Mei Chih |
Disclosed are biomarkers for Barrett's esophagus and esophageal adenocarcinoma, and uses thereof, such as in methods for detecting the presence, and monitoring progression, of Barrett's esophagus and esophageal adenocarcinoma. Also disclosed are methods for treating and methods of monitoring the treatment of Barrett's esophagus and esophageal adenocarcinoma, as well as kits and compositions for use in such methods.
WO/2016/077890 A BUILDING ELEMENT||WO||26.05.2016|
||PCT/AU2015/050733||KNEW POD SYSTEMS PTY LTD ||SAUNDERS, Kevin |
A building element for forming a slab or a foundation with a settable material includes a body having an upper surface, a bottom, and sidewalls extending from the upper surface to the bottom. A hole is defined in the body. At least one rib-forming channel extends across the upper surface and intersects with the hole. Cavities are formed in the bottom of the body.
WO/2016/077885 FRAGRANT NAIL POLISH||WO||26.05.2016|
||PCT/AU2015/050727||PURE EUPHORIA PTY LTD ||WRIGHT, Jackie |
The present invention provides a fragrant nail polish. The fragrant nail polish is made fragrant by essential oil. The film-former, solvents and resins in the polish are stabilised by stabilising agents.
WO/2016/077877 METALLOPROTEIN COMPOSITIONS||WO||26.05.2016|
||PCT/AU2015/050717||COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION ||SUTHERLAND, Tara |
The present invention relates to compositions comprising: a polypeptide, wherein at least a portion of the polypeptide has a coiled coil structure; and a chelate comprising a chelating agent and a metal ion; and wherein the chelate is bound to at least one amino acid of the polypeptide. In a preferred embodiment the polypeptide is a silk fibroin, wherein at least a portion of said silk fibroin has a coiled coil structure.
WO/2016/077864 METHOD FOR THE PROCESSING OF POTASSIUM CONTAINING MATERIALS||WO||26.05.2016|
||PCT/AU2015/000691||K-MAX PTY LTD ||JOHNSON, Gary Donald |
A method for the processing of potassium containing materials, the method comprising the steps of: (i) Passing a potassium containing material to a first separation step in which a potassium containing mineral is separated from gangue minerals present; (ii) Leaching the potassium containing mineral (1) in acid in a leach step (40) whereby substantially all potassium, iron, aluminium and magnesium present is solubilised and a mixed potassium/iron double salt formed; (iii) Selectively crystallising the mixed potassium/iron double salt formed in the leach step (40) of step (ii) in a crystallisation step (60); (iv) Passing a liquor from the crystallising step (iii) (60) to a second separation step (70) to separate the mixed potassium/iron double salt formed in step (iii); (v) Passing the double salt (16) to a thermal decomposition step (100) to produce an iron oxide, a potassium salt and one or more phosphates; (vi) Leaching (120) the product (20) of the thermal decomposition step (100); (vii) Passing a leach liquor from step (vi) to a third separation step (130) to separate the iron oxide and phosphate from the potassium salt; (viii) Recovering the potassium salt by crystallisation (140); (ix) Separating the iron oxide and phosphate of step (vii) by leaching (160) and subsequent solid liquid separation (170); and (x) Precipitating phosphate (34) in a phosphorous precipitation step (180) from a liquor (32) produced in step (ix) through the addition of a base (33) thereto.
WO/2016/077865 SINGLE/LIMITED ANGLE GAMMA/X-RAY TOMOGRAPHY||WO||26.05.2016|
||PCT/AU2015/000695||MONASH UNIVERSITY ||BROWN, Jeremy Michael Cooney |
A tomography system (30) comprises one or more first radiation detectors (42) and one or more large area sources of gamma rays or x-rays (32). In use, the one or more first radiation detectors (42) detect photons transmitted through at least part of an object positioned in the path of the respective beam of radiation and output first data describing the positions on the detection face of the respective first radiation detector (42) at which transmitted photons are received. The system also comprise at least one scatter camera (38). Each scatter camera (38) is positioned laterally of each beam of radiation to receive photons scattered from the object.